Heimo Lagler

Has grant

Associate Professor

Medical University of Vienna

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Microbiology Microbiology professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Heimo Lagler is an Associate Professor at the Medical University Vienna, Austria. His research focuses on antimicrobial resistance, including studies on resistance mechanisms in various pathogens, and the clinical implications of infections in vulnerable populations. Recent publications include investigations into the resistance of MRSA strains and the efficacy of treatments for malaria in pregnant women with HIV. His work contributes to a deeper understanding of infectious diseases and their management in clinical settings.

Recent Grants

Grant: Close

Vienna Echinococcosis Study: A Prospective Cohort Study

Open Date: 2022-01-01

Close Date: 2024-01-01

Articles (20)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (13)

Martin Bauer

Medical University of Vienna

AUSTRIA

View details

Lorenz Schubert

Medical University of Vienna

AUSTRIA

View details

Jon Ulf Hansen

Statens Serum Institut

DENMARK

View details

Sergi Sanz Bravo

Biostatistic, Head of Unit

Barcelona Institute for Global Health

SPAIN

View details

David Chromy

Medical University of Vienna

AUSTRIA

View details

Herbert Auer

Professor

AUSTRIA

View details

Myriam El Gaaloul

Head o Clinical Sciences & Regulatory

Medicines for Malaria Venture

SWITZERLAND

View details

Christoph Steininger

Medical University of Vienna

AUSTRIA

View details

Ludwig Traby

Medical University of Vienna

AUSTRIA

View details

Kathrin Spettel

Lecturer and Researcher

Fachhochschule Campus Wien

AUSTRIA

View details

Michael Ramharter

Professor

Bernhard-Nocht-Institut für Tropenmedizin

GERMANY

View details

Birgit Willinger

Medical University of Vienna

AUSTRIA

View details

Johannes Mischlinger

Bernhard Nocht Institute for Tropical Medicine

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Heimo Lagler

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

In vitro long-term exposure to chlorhexidine or triclosan induces cross-resistance against azoles in Nakaseomyces glabratus.

Unraveling novel mutation patterns and morphological variations in two dalbavancin-resistant MRSA strains in Austria using whole genome sequencing and transmission electron microscopy.

In vitro resistance development gives insights into molecular resistance mechanisms against cefiderocol.

Prevalence and clinical implications of bloodstream infections in intensive care patients with or without burn injury: a retrospective cohort study.

Safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial.

Cystic Echinococcosis in Paediatric Refugees: A Case Series.

Candida auris in Austria—What Is New and What Is Different

Differences in oxazolidinone resistance mechanisms and small colony variants emergence of <i>Staphylococcus aureus</i> induced in an <i>in vitro</i> resistance development model.

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.

Diaphragmatic perforation as a result of cystic echinococcosis in an HIV-positive migrant

Treatment of legionellosis including a single intravenous dose of 1.5 g azithromycin: 18-year experience at a tertiary care hospital

Isolated peritoneal involvement as a primary manifestation of cystic echinococcosis.

Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double-blind, placebo-controlled Phase 2 trial.

Comparison of non-invasive Staphylococcus aureus sampling methods on lesional skin in patients with atopic dermatitis

Evaluation of Eosinophilic Cationic Protein as a Marker of Alveolar and Cystic Echinococcosis

Isolated peritoneal involvement as a primary manifestation of cystic echinococcosis

Evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women: protocol of a multicentre, two-arm, randomised, placebo-controlled, superiority clinical trial (MAMAH project).

Azithromycin concentrations during long-term regimen, a pilot study in patients with MALT lymphoma.

Bone turnover markers can predict healing time in medication-related osteonecrosis of the jaw.

A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9.

Collaborators (13)

Martin Bauer

Lorenz Schubert

Jon Ulf Hansen

Sergi Sanz Bravo

David Chromy

Herbert Auer

Myriam El Gaaloul

Christoph Steininger

Ludwig Traby

Kathrin Spettel

Michael Ramharter

Birgit Willinger

Johannes Mischlinger

Make your next move.